Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19

Jessa Hospital

Status

Completed

Conditions

COVID-19

Treatments

Procedure: ECMO

Study type

Observational

Funder types

Other

Identifiers

NCT05158816

f/2021/097

Details and patient eligibility

About

Retrospective single center analyses of COVID-19 patients admitted to the ICU between 01/02/2020 and 31/07/2021.

Full description

All adults (>18 years) with acute hypoxaemic respiratory failure due to diagnosed COVID-19 pneumonia and admitted to ICU from 01/02/2020 until 31/07/2021 were included in the study. Following the World Health Organisation (WHO) protocol 19, laboratory confirmation of COVID-19 infection was defined as a positive result on polymerase chain reaction (PCR) assays of nasopharyngeal swab samples or bronchoalveolar lavage. Only laboratory-confirmed patients were included in the analysis.

Additional data collection

Additional collected parameters are listed below and are collected as a standard-of-care in our hospital:

Demographics: i.e age, gender, BMI
DNR code
Comorbidities: smoking, obesity, hypertension, diabetes, cardiovascular disease, respiratory disease, malignancies, renal failure (AKI), liver failure, gastrointestinal disease, neurological conditions, mental state, other
Symptoms at the time of admission to ICU: i.e fever, body temperature, dyspnoea, headache, diarrhea etc...
Laboratory results of all standard parameters measured
Treatment: antiviral agents, antibiotics, etc...
Complications: shock, heart failure, sepsis, stroke, etc...
Ventilation: method, PEEP, FiO2, P/F ratio ..

Enrollment

295 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All adult COVID-19 patients (>18 years) admitted to the ICU between 01/02/2020 and 31/07/2021 with a laboratory confirmation of COVID-19 infection with a positive result on polymerase chain reaction (PCR) assays of nasopharyngeal swab samples or bronchoalveolar lavage

Exclusion criteria